ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 129 filers reported holding ALLAKOS INC in Q1 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $355,190 | -24.4% | 79,818 | +43.1% | 0.00% | 0.0% |
| Q4 2022 | $469,685 | +0.6% | 55,782 | -32.0% | 0.00% | 0.0% |
| Q1 2022 | $467,000 | +102.2% | 81,994 | +4878.4% | 0.00% | 0.0% |
| Q4 2020 | $231,000 | +335.8% | 1,647 | +196.2% | 0.00% | – |
| Q4 2019 | $53,000 | +20.5% | 556 | 0.0% | 0.00% | – |
| Q3 2019 | $44,000 | -93.8% | 556 | -96.8% | 0.00% | -100.0% |
| Q1 2019 | $710,000 | – | 17,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
| Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
| TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
| Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
| Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
| Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
| NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
| COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
| BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
| Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |